The zoonotic pathogen Wohlfahrtiimonas chitiniclastica - current findings from a clinical and genomic perspective

BMC Microbiol. 2024 Jan 3;24(1):3. doi: 10.1186/s12866-023-03139-7.

Abstract

The zoonotic pathogen Wohlfahrtiimonas chitiniclastica can cause several diseases in humans, including sepsis and bacteremia. Although the pathogenesis is not fully understood, the bacterium is thought to enter traumatic skin lesions via fly larvae, resulting in severe myiasis and/or wound contamination. Infections are typically associated with, but not limited to, infestation of an open wound by fly larvae, poor sanitary conditions, cardiovascular disease, substance abuse, and osteomyelitis. W. chitiniclastica is generally sensitive to a broad spectrum of antibiotics with the exception of fosfomycin. However, increasing drug resistance has been observed and its development should be monitored with caution. In this review, we summarize the currently available knowledge and evaluate it from both a clinical and a genomic perspective.

Keywords: Antibiotic resistance; Arsenic resistance; Wohlfahrtiimonas chitiniclastica; “One health” approach.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Diptera* / microbiology
  • Gammaproteobacteria* / genetics
  • Genomics
  • Humans
  • Larva

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • Wohlfahrtiimonas chitiniclastica